These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10449288)

  • 81. The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml.
    Easterbrook PJ; Ives N; Waters A; Mullen J; O'Shea S; Peters B; Gazzard BG
    AIDS; 2002 Jul; 16(11):1521-7. PubMed ID: 12131190
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
    Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
    AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan.
    Deng SC; Chen MY; Hsieh SM; Sheng WH; Hsiao CF; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2003 Mar; 36(1):10-4. PubMed ID: 12741726
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia.
    Aboulafia DM; Bundow D; Waide S; Bennet C; Kerr D
    Am J Med Sci; 2000 Aug; 320(2):117-23. PubMed ID: 10981487
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance.
    Cohen Stuart JW; Wensing AM; Kovacs C; Righart M; de Jong D; Kaye S; Schuurman R; Visser CJ; Boucher CA
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):105-13. PubMed ID: 11588503
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: a meta-analysis.
    Batterham MJ
    Am J Clin Nutr; 2005 Mar; 81(3):702-13. PubMed ID: 15755842
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men.
    Lampinen TM; Critchlow CW; Kuypers JM; Hurt CS; Nelson PJ; Hawes SE; Coombs RW; Holmes KK; Kiviat NB
    AIDS; 2000 Mar; 14(5):F69-75. PubMed ID: 10780708
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
    Bassetti S; Battegay M; Furrer H; Rickenbach M; Flepp M; Kaiser L; Telenti A; Vernazza PL; Bernasconi E; Sudre P
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):114-9. PubMed ID: 10360802
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.
    Ferrando S; van Gorp W; McElhiney M; Goggin K; Sewell M; Rabkin J
    AIDS; 1998 May; 12(8):F65-70. PubMed ID: 9631133
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect of HAART on HIV RNA trajectory among treatment-naïve men and women: a segmental Bernoulli/lognormal random effects model with left censoring.
    Chu H; Gange SJ; Li X; Hoover DR; Liu C; Chmiel JS; Jacobson LP
    Epidemiology; 2010 Jul; 21 Suppl 4(0 4):S25-34. PubMed ID: 20386106
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
    Merenstein D; Wang C; Gandhi M; Robison E; Levine AM; Schwartz RM; Weber KM; Liu C
    Complement Ther Med; 2012 Aug; 20(4):222-7. PubMed ID: 22579434
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects.
    Fitch KV; Guggina LM; Keough HM; Dolan Looby SE; Hadigan C; Anderson EJ; Hubbard J; Liebau JG; Johnsen S; Wei J; Makimura H; Stanley TL; Lo J; Grinspoon SK
    Metabolism; 2009 May; 58(5):608-15. PubMed ID: 19375582
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).
    Navazesh M; Mulligan R; Karim R; Mack WJ; Ram S; Seirawan H; Greenspan J; Greenspan D; Phelan J; Alves M;
    Oral Dis; 2009 Jan; 15(1):52-60. PubMed ID: 19017280
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Treatment of HIV disease in the new millennium.
    Kak V; MacArthur RD; Crane LR
    Semin Thorac Cardiovasc Surg; 2000 Apr; 12(2):140-4. PubMed ID: 10807436
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients.
    McNaghten AD; Hanson DL; Dworkin MS; Jones JL;
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):499-505. PubMed ID: 12679701
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.
    Rezza G; Lepri AC; d'Arminio Monforte A; Pezzotti P; Castelli F; Dianzani F; Lazzarin A; De Luca A; Arlotti M; Leoncini F; Manconi PE; Rizzardini G; Minoli L; Poggio A; Ippolito G; Phillips AN; Moroni M
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):56-62. PubMed ID: 11064505
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART.
    Samperiz G; Fanjul F; Valera JL; Lopez M; Rios Á; Peñaranda M; Campins A; Riera M; Agusti A
    PLoS One; 2019; 14(10):e0224510. PubMed ID: 31661533
    [TBL] [Abstract][Full Text] [Related]  

  • 98. AIDS update 1999: viral reservoirs and immune-based therapies.
    Isada CM; Calabrese LH
    Cleve Clin J Med; 1999 May; 66(5):267-9. PubMed ID: 10330777
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sex differences in HAART-associated dyslipidaemia.
    Pernerstorfer-Schoen H; Jilma B; Perschler A; Wichlas S; Schindler K; Schindl A; Rieger A; Wagner OF; Quehenberger P
    AIDS; 2001 Apr; 15(6):725-34. PubMed ID: 11371687
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sex differences in the associations of HIV disease characteristics and body composition in antiretroviral-naive persons.
    Visnegarwala F; Raghavan SS; Mullin CM; Bartsch G; Wang J; Kotler D; Gibert CL; Shlay J; Grunfeld C; Carr A; El-Sadr W
    Am J Clin Nutr; 2005 Oct; 82(4):850-6. PubMed ID: 16210716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.